Healthcare Sales & Marketing Network News: Gilead

Searching News Database: Gilead

HSMN NewsFeed - 15 May 2024
Compugen Appoints David Silberman as Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Apr 2024
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Feb 2024
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 1 Nov 2023
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Oct 2023
Mozart Therapeutics Expands Executive Leadership Team with Appointments of Dr. Jason Chien, Chief Medical Officer, and Russ Hawkinson, Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Sep 2023
OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 3 Aug 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jul 2023
Velia Therapeutics Announces Appointment of Veteran Drug Developer, John McHutchison, AO, MD as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Feb 2023
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Jan 2023
ZyVersa Therapeutics Appoints Three New Board Members
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 21 Jun 2022
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Mar 2022
Pathalys Pharma Announces Executive Team Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Sep 2021
Kyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 May 2021
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Feb 2021
Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jan 2021
Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Nov 2020
Athos Therapeutics Announces Appointment of Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jun 2020
Cipla Launches CIPREMI (remdesivir Lyophilised Powder for Injection 100 mg), the Only U.S. FDA Approved Emergency Use Authorisation (EUA) Treatment for Patients With Severe COVID-19 Disease
Biopharmaceuticals Product Launch

HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2020
DURECT Corporation Announces Outcome of FDA Advisory Committee Meeting for POSIMIR(R)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 13 Jan 2020
Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 8 Jan 2020
Provention Bio Appoints Jason Hoitt as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Dec 2019
Apexigen Expands Leadership Team with Two Key Appointments in CMC and Clinical Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 Oct 2019
DURECT Announces FDA Advisory Committee Meeting to Review POSIMIR(R) for the Treatment of Post-Surgical Pain
Biopharmaceuticals Drug Delivery Surgery FDA

HSMN NewsFeed - 21 Aug 2019
Vanda Pharmaceuticals Announces the Appointments of a Chief Corporate Affairs and Communications Officer and a Chief Marketing Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2019
Asceneuron Appoints Peter Van Vlasselaer as Chairman
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 5 Nov 2018
Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Oct 2018
Akero Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2018
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 12 Sep 2018
Sutro Taps Worsley as Chief Business Officer; Names Fitzpatrick as People and Communications Chief
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 11 Sep 2018
Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 31 Jul 2018
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience
Diagnostics Oncology Personnel

HSMN NewsFeed - 12 Jul 2018
Synthorx Expands Leadership Team with Three Key Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2018
Bridge Medicines Appoints Louis M. Renzetti, Ph.D., As Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Mar 2018
Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Feb 2018
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 5 Feb 2018
BrainStorm Cell Therapeutics Appoints Senior Kite Executive, Anthony Polverino, Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Biopharmaceuticals Drug Delivery Ophthalmology Personnel

HSMN NewsFeed - 17 Oct 2017
Menlo Therapeutics Expands its Management Team
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 3 Oct 2017
Oncorus(R), Inc., Names Christophe Quéva, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 10 Aug 2017
Mylan Advances Access in the Fight Against HIV with the Launch of Three Generic Antiretroviral Medicines in Canada
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 7 Apr 2017
FDA Approves Two Hepatitis C Drugs for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Mar 2017
OncoResponse Announces Final Closing of $22.5M Series A Financing Round
Biopharmaceuticals Oncology Personnel Venture Capital

HSMN NewsFeed - 4 Jan 2017
Alessandro Riva, MD, to Join Gilead as Senior Vice President, Hematology and Oncology Therapeutic Area Head
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Nov 2016
Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 18 Nov 2016
GlobeImmune Announces Updates
Biopharmaceuticals Licensing Personnel

HSMN NewsFeed - 17 Nov 2016
Gilead Sciences Announces Promotion of James R. Meyers to Executive Vice President, Worldwide Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2016
Assembly Biosciences Announces Key Additions to Microbiome Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 May 2016
Bioniz Therapeutics Appoints Fredrik Wiklund as Chief Operating Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 28 Apr 2016
Pliant Therapeutics Expands Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Apr 2016
AnaptysBio Appoints Dr. Matthew Moyle As Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Mar 2016
Accera Appoints Ernest Wong, Ph.D., as Head of Corporate Development
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 24 Feb 2016
Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs
Biopharmaceuticals Oncology Venture Capital Licensing

HSMN NewsFeed - 29 Jan 2016
Gilead’s John C. Martin, PhD to Assume Role of Executive Chairman of the Board; John F. Milligan, PhD to Be Appointed Chief Executive Officer and Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jan 2016
Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib
Biopharmaceuticals

HSMN NewsFeed - 17 Dec 2015
Galapagos and Gilead Announce Global Partnership to Develop Filgotinib for the Treatment of Rheumatoid Arthritis and Other Inflammatory Diseases
Biopharmaceuticals

HSMN NewsFeed - 3 Dec 2015
ProNAi Therapeutics Appoints Dr. Keith Anderson and Dr. Gregg Smith to its Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Nov 2015
Calimmune Expands Board of Directors, Names R. Scott Greer as Chairman
Biopharmaceuticals HIV/AIDS Personnel

HSMN NewsFeed - 11 Sep 2015
Akebia Therapeutics Announces Additions to its Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2015
Atopix Therapeutics Appoints Dr Andrew Zambanini as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jul 2015
KalVista Pharmaceuticals Raises $33 Million to Advance Development of Novel Plasma Kallikrein Inhibitors in Diabetic Macular Edema and Hereditary Angioedema
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Jul 2015
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jul 2015
AnaptysBio Secures $40 Million Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Jul 2015
Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners
Biopharmaceuticals Devices Venture Capital Personnel

HSMN NewsFeed - 10 Jun 2015
GlobeImmune Announces Evaluation of Strategic Alternatives and Corporate Restructuring
Biopharmaceuticals

HSMN NewsFeed - 6 May 2015
Gilead Sciences Acquires EpiTherapeutics
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 14 Apr 2015
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Feb 2015
Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi(R) and Harvoni(R) in India
Biopharmaceuticals Distribution

HSMN NewsFeed - 19 Sep 2014
European Commission Grants Marketing Authorization for Gilead’s Zydelig(R) (Idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 5 Sep 2014
OnCore Biopharma Closes Series R Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Sep 2014
ProNAi Therapeutics, Inc. Names New President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Aug 2014
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2014
Ventrus Biosciences to Merge With Assembly Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2014
Gilead’s Sovaldi(R) Demonstrates Efficacy and Safety Among Chronic Hepatitis C Patients with Advanced Liver Disease
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2014
Gilead Announces Results from Study of Sovaldi(R) for Retreatment of Chronic Hepatitis C in Patients Not Cured with Prior Antiviral Therapy
Biopharmaceuticals

HSMN NewsFeed - 9 Apr 2014
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Mar 2014
Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
Devices Wound Care Personnel

HSMN NewsFeed - 14 Mar 2014
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
Biopharmaceuticals Litigation

HSMN NewsFeed - 19 Feb 2014
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 31 Jan 2014
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India
Biopharmaceuticals Distribution

HSMN NewsFeed - 17 Jan 2014
European Commission Grants Marketing Authorization for Gilead’s Sovaldi(R) (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Jan 2014
Gilead Sciences’ Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 6 Dec 2013
U.S. Food and Drug Administration Approves Gilead’s Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Dec 2013
Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences
Biopharmaceuticals Litigation

HSMN NewsFeed - 8 Oct 2013
Omeros Hires Michael K. Inouye to Lead Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2013
Heat Biologics Appoints Louis C. Bock to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Aug 2013
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Aug 2013
Alexza Announces Management Promotions
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 26 Jul 2013
Adimab Announces First Antibody Technology Transfer and License Agreement with GlaxoSmithKline
Biopharmaceuticals Licensing

HSMN NewsFeed - 22 Jul 2013
ARCA biopharma Announces Additions to GENETIC-AF Leadership Team
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 19 Jul 2013
Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2013
Mevion Medical Systems Secures $55 Million to Accelerate the Deployment of Its Revolutionary Cancer Treatment Technology
Devices Oncology Venture Capital

HSMN NewsFeed - 5 Jun 2013
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
Diagnostics Personnel

HSMN NewsFeed - 20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 15 May 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 May 2013
Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA(R) (efavirenz) in HIV-1 Infected Pediatric Patients
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 15 Apr 2013
Royalty Pharma Announces Firm Offer to Acquire Elan
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Mar 2013
Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2012
Resolve Therapeutics Raises $5.8 Million in Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Oct 2012
Omeros Adds Vice Presidents of Regulatory and Clinical to Management Team
Biopharmaceuticals Neurology Surgery Personnel

HSMN NewsFeed - 25 Apr 2012
Threshold Pharmaceuticals Appoints Robert Simon as Senior Vice President of Regulatory Affairs
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Mar 2012
Aragon Pharmaceuticals Secures $42 Million in Series C Financing to Advance Pipeline of Therapies Targeting Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 10 Jan 2012
Interwest Partners Expands Medical Devices Team
Devices Venture Capital Personnel

HSMN NewsFeed - 6 Dec 2011
Theraclone Sciences Announces Appointment of Clifford Stocks as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2011
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2011
Mylan's Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 25 May 2011
BioCryst Pharmaceuticals Announces Appointment of Thomas Staab as Its Next Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2011
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
Biopharmaceuticals HIV/AIDS Personnel

HSMN NewsFeed - 25 Mar 2011
FDA Approves Zyclara(R) (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Feb 2011
Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 7 Feb 2011
Cellerant Therapeutics Announces Key Additions to Sr. Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Feb 2011
Alios BioPharma Names Carol L. Brosgart, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Dec 2010
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 20 Dec 2010
Gilead Sciences to Acquire Arresto Biosciences for $225 Million
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Dec 2010
AVI BioPharma Names Chris Garabedian Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Dec 2010
EHSI Acquires Stem Cell Biotech Firm Celulas Genetica
Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 29 Sep 2010
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2010
Third Rock Ventures Raises $426 Million Fund II
Venture Capital Personnel

HSMN NewsFeed - 3 Sep 2010
Gilead Sciences Submits European Marketing Application for Once-Daily Single-Tablet Regimen of Truvada(R) and TMC278 for the Treatment of HIV Infection
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jul 2010
Chimerix Appoints Two New Vice Presidents to Clinical Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2010
Spectrum Pharmaceuticals Appoints George Tidmarsh, M.D., Ph.D, as Senior Vice President, Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2010
Abbott's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 25 Jun 2010
Gilead Sciences to Acquire CGI Pharmaceuticals for up to $120 Million
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Mar 2010
MicroPhage, Inc. appoints Alene A. Campbell as CEO
Diagnostics Personnel

HSMN NewsFeed - 22 Feb 2010
QLT Names Joseph L. Turner to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2010
Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 19 Jan 2010
PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2010
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2010
Intuity Medical Closes $64 Million Series D Financing - One of the Largest Medical Device Funding Events of 2009
Devices Monitoring Endocrinology Venture Capital

HSMN NewsFeed - 22 Dec 2009
PTC Therapeutics Closes $50 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Dec 2009
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Nov 2009
Four Senior Executives Join Orexigen(R) Therapeutics Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Nov 2009
NeurogesX Expands Commercial Operations Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Sep 2009
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 18 Aug 2009
Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 3 Aug 2009
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jul 2009
OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2009
Depomed Names Shay Weisbrich Vice President of Marketing
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 1 Jun 2009
PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Apr 2009
Gilead Sciences Completes Acquisition of CV Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Mar 2009
Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 19 Mar 2009
European CHMP Adopts Negative Opinion on Aztreonam Lysine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Feb 2009
Gilead Receives Response From U.S. FDA on Company's Request for Formal Dispute Resolution for Aztreonam for Inhalation Solution
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 11 Feb 2009
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jan 2009
BAROFOLD, INC. APPOINTS J. WILLIAM FREYTAG, Ph.D. AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jan 2009
Horizon Therapeutics Announces Senior Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Nov 2008
Awarepoint Corporation Closes $13.3 M Series D Financing Round
Devices Venture Capital

HSMN NewsFeed - 19 Nov 2008
Tengion Announces Second Closing of Series C Financing
Regenerative Medicine Venture Capital

HSMN NewsFeed - 28 Oct 2008
Gilead Announces Two-Year Clinical Data for Letairis(R) (ambrisentan) for the Treatment of Pulmonary Arterial Hypertension (WHO Group 1)
Biopharmaceuticals

HSMN NewsFeed - 11 Sep 2008
Seigo Izumo, MD Joins Gilead as Senior Vice President, Cardiovascular Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Aug 2008
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Aug 2008
Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla(R) (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries
Biopharmaceuticals HIV/AIDS Distribution

HSMN NewsFeed - 8 Jul 2008
Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jun 2008
Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 29 May 2008
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 29 May 2008
Data from Pivotal Phase III Studies of Gilead's Letairis(R) (ambrisentan) for Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms Published in Circulation
Biopharmaceuticals

HSMN NewsFeed - 25 Apr 2008
European Commission Approves Viread(R) for Chronic Hepatitis B
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 Mar 2008
Gilead Sciences Submits Marketing Authorisation Application for Aztreonam Lysine 75 mg Powder for Nebuliser Solution, a Potential New Treatment for Cystic Fibrosis, to European Medicines Agency
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Mar 2008
Gilead Appoints Dr. John J. Toole as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jan 2008
Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jan 2008
Gilead Announces Departure of Caroline Dorsa
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jan 2008
Oculus Innovative Sciences, Inc. Appoints Gregg Alton to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2008
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
Devices Dermatology Venture Capital

HSMN NewsFeed - 11 Dec 2007
Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 4 Dec 2007
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
Biopharmaceuticals HIV/AIDS Generics FDA

HSMN NewsFeed - 26 Nov 2007
Achillion Announces Appointment of New Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2007
Significant Changes in Store for Growing HIV Market
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 6 Nov 2007
Gilead and LG Life Sciences Announce Global License Agreement to Advance Novel Drug Candidates for Treatment of Fibrotic Diseases
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Nov 2007
Gilead Announces 48-Week Data from Two Pivotal Phase III Studies Evaluating Viread(R) For the Treatment of Chronic Hepatitis B
Biopharmaceuticals

HSMN NewsFeed - 29 Oct 2007
Gilead Announces 48-Week Data Evaluating Switching from Combivir(R) To Truvada(R) Among Virologically-Suppressed HIV Patients
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 23 Oct 2007
Gilead Announces New LetairisTM (ambrisentan) Data for the Treatment of Patients with Pulmonary Arterial Hypertension (WHO Group 1)
Biopharmaceuticals

HSMN NewsFeed - 18 Oct 2007
Caroline Dorsa to Join Gilead as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2007
European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
Biopharmaceuticals HIV/AIDS Regulatory

HSMN NewsFeed - 17 Oct 2007
Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
Biopharmaceuticals Regulatory HIV/AIDS

HSMN NewsFeed - 10 Oct 2007
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 4 Oct 2007
Gilead Announces Detailed Results of Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2007
BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2007
New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 1 Aug 2007
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
Biopharmaceuticals HIV/AIDS Venture Capital Personnel

HSMN NewsFeed - 23 Jul 2007
144-Week Data from Gilead's Study 934 Comparing Truvada(R) to Combivir(R) Both in Combination with Sustiva(R) Presented At International AIDS Society Meeting in Sydney
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 11 Jul 2007
J. William Freytag, PH.D. appointed Chairman and Chief Executive Officer of Aspreva Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2007
Tamiflu(R) 30 mg and 45 mg Capsules Approved by U.S. Food and Drug Administration
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jun 2007
Second Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
Biopharmaceuticals

HSMN NewsFeed - 21 Jun 2007
Presidio Pharmaceuticals Announces Key Executive Management Additions
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jun 2007
Plexxikon Expands Management Team and Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jun 2007
U.S. Food and Drug Administration Approves Gilead's Letairis(TM) (ambrisentan) 5 mg and 10 mg Tablets for the Once-Daily Treatment of Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Jun 2007
Seattle Genetics Adds Industry Veterans John P. McLaughlin and Daniel G. Welch to its Board of Directors and Promotes Eric Dobmeier to Chief Business Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Jun 2007
Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
Biopharmaceuticals

HSMN NewsFeed - 29 May 2007
Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 21 May 2007
Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
Biopharmaceuticals

HSMN NewsFeed - 17 May 2007
Achillion Announces the Resignation of John C. Pottage, Jr., M.D., Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 May 2007
Achillion Appoints OSI Executive Robert Van Nostrand to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 May 2007
Gilead Sciences Announces Senior Management Promotion
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 May 2007
Pharmacyclics Announces Appointment of Michael K. Inouye as Senior Vice President of Corporate and Commercial Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 May 2007
Royalty Pharma Acquires a Portion of New York University's Royalty Interest in Remicade(R) for $650 Million
Biopharmaceuticals

HSMN NewsFeed - 1 May 2007
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 30 Apr 2007
ReVision Optics, Inc. Raises $25M in Series D Financing
Devices Ophthalmology Venture Capital

HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Apr 2007
Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals Devices

HSMN NewsFeed - 9 Mar 2007
Roche Files Supplemental New Drug Application with U.S. Food & Drug Administration for Tamiflu(R) 30 mg and 45 mg Capsules
Biopharmaceuticals

HSMN NewsFeed - 9 Mar 2007
Gilead Sciences Announces New Appointments within Executive Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Feb 2007
Merck & Co., Inc. (1) To Distribute ATRIPLA(TM) in Developing Countries
Biopharmacetuicals HIV/AIDS

HSMN NewsFeed - 2 Feb 2007
Veteran Pharmaceutical Executive Joins AerovectRx Corp. Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jan 2007
Carla A. Hills Joins Gilead Sciences' Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jan 2007
Aerovance Names Mark L. Perry President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Dec 2006
Gilead Announces Preliminary Results From Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2006
Gilead Submits New Drug Application To U.S. FDA for Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals

HSMN NewsFeed - 15 Dec 2006
96-Week Data From Gilead's Study 934 Comparing Viread(R) and Emtriva(R) to Combivir(R) Both in Combination With Sustiva(R) Published in Journal of Acquired Immune Deficiency Syndrome
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 14 Nov 2006
Bristol-Myers Squibb Company Announces Promotion of Andrew Bonfield and Elliott Sigal to Executive Vice Presidents
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2006
Interim Analysis of New Study Suggests Boosted INVIRASE(R) May Achieve Similar Levels of HIV Suppression to Boosted Lopinavir with a Favorable Lipid Profile
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 7 Nov 2006
KAI Pharmaceuticals Appoints Dr. Dirk Mendel as Vice President, Pharmacology & Preclinical Pharmacokinetics and Pharmacodynamics
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Oct 2006
Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Oct 2006
Royalty Pharma Announces Agreement Regarding the Purchase of the Rights to a Pre-Existing Royalty Interest in HUMIRA(R) From AstraZeneca and CAT
Biopharmaceuticals

HSMN NewsFeed - 9 Oct 2006
Diatos Strengthens Management Team with the Appointment of New Chief Medical Officer and New Chief Sales & Marketing Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Oct 2006
Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit Marketing Authorisation Application for ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) to European Medicines Agency
Biopharmaceuticals Regulatory HIV/AIDS

HSMN NewsFeed - 2 Oct 2006
Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Sep 2006
Bristol-Myers Squibb and Gilead Sciences establish agreement to commercialize ATRIPLA(TM) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Canada
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 28 Sep 2006
Bristol-Myers Squibb and Gilead Sciences Establish Agreement to Commercialize ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) in Canada
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 14 Sep 2006
Avera Pharmaceuticals Names Dinu Sen Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2006
Metastatix Completes Series a Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Jul 2006
U.S. Food and Drug Administration (FDA) Approves ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), The First Once-Daily Single Tablet Regimen for Adults with HIV-1 Infection
Biopharmaceuticals FDA HIV/AIDS

HSMN NewsFeed - 10 Jul 2006
Cardinal Health Signs Agreement With Roche to Manufacture Tamiflu(R)
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2006
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2006
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome(R) from Gilead Sciences
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 8 May 2006
Connetics Names Sunil Patel Vice President, Corporate Development and Strategy
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 90

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 90 additional stories matching:
Gilead
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.